These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35870616)

  • 1. Alpha synuclein processing by MMP-3 - implications for synucleinopathies.
    Bluhm A; Schrempel S; Moceri S; Stieler J; Feja M; Schilling S; Schulze A; von Hörsten S; Hartlage-Rübsamen M; Richter F; Roßner S
    Behav Brain Res; 2022 Sep; 434():114020. PubMed ID: 35870616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.
    Hartlage-Rübsamen M; Bluhm A; Moceri S; Machner L; Köppen J; Schenk M; Hilbrich I; Holzer M; Weidenfeller M; Richter F; Coras R; Serrano GE; Beach TG; Schilling S; von Hörsten S; Xiang W; Schulze A; Roßner S
    Acta Neuropathol; 2021 Sep; 142(3):399-421. PubMed ID: 34309760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical Demonstration of the pGlu79 α-Synuclein Fragment in Alzheimer's Disease and Its Tg2576 Mouse Model.
    Bluhm A; Schrempel S; Schilling S; von Hörsten S; Schulze A; Roßner S; Hartlage-Rübsamen M
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregated Alpha-Synuclein Inclusions within the Nucleus Predict Impending Neuronal Cell Death in a Mouse Model of Parkinsonism.
    Weston LJ; Bowman AM; Osterberg VR; Meshul CK; Woltjer RL; Unni VK
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
    Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
    Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of 14-3-3 protein-protein interactions with Fusicoccin-A decreases alpha-synuclein dependent cell-autonomous death in neuronal and mouse models.
    Vinueza-Gavilanes R; Bravo-González JJ; Basurco L; Boncristiani C; Fernández-Irigoyen J; Santamaría E; Marcilla I; Pérez-Mediavilla A; Luquin MR; Vales A; González-Aseguinolaza G; Aymerich MS; Aragón T; Arrasate M
    Neurobiol Dis; 2023 Jul; 183():106166. PubMed ID: 37245833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathies.
    Moors TE; Mona D; Luehe S; Duran-Pacheco G; Spycher L; Mundigl O; Kaluza K; Huber S; Hug MN; Kremer T; Ritter M; Dziadek S; Dernick G; van de Berg WDJ; Britschgi M
    Acta Neuropathol Commun; 2022 Jun; 10(1):82. PubMed ID: 35659116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.
    Lashuel HA
    Neurobiol Dis; 2020 Jul; 141():104876. PubMed ID: 32339655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response.
    Delaidelli A; Richner M; Jiang L; van der Laan A; Bergholdt Jul Christiansen I; Ferreira N; Nyengaard JR; Vægter CB; Jensen PH; Mackenzie IR; Sorensen PH; Jan A
    Acta Neuropathol Commun; 2021 Jun; 9(1):105. PubMed ID: 34092244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
    Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
    Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.
    Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D
    Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse.
    Savolainen MH; Richie CT; Harvey BK; Männistö PT; Maguire-Zeiss KA; Myöhänen TT
    Neurobiol Dis; 2014 Aug; 68():1-15. PubMed ID: 24746855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay.
    Arlinghaus R; Iba M; Masliah E; Cookson MR; Landeck N
    J Parkinsons Dis; 2023; 13(2):255-270. PubMed ID: 36847016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy.
    Lin S; Leitão ADG; Fang S; Gu Y; Barber S; Gilliard-Telefoni R; Castro A; Sung K; Shen R; Florio JB; Mante ML; Ding J; Spencer B; Masliah E; Rissman RA; Wu C
    Neurobiol Dis; 2023 Mar; 178():106010. PubMed ID: 36702318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Young human alpha synuclein transgenic (BAC-SNCA) mice display sex- and gene-dose-dependent phenotypic disturbances.
    Moceri S; Bäuerle N; Habermeyer J; Ratz-Wirsching V; Harrer J; Distler J; Schulze-Krebs A; Timotius IK; Bluhm A; Hartlage-Rübsamen M; Roßner S; Winkler J; Xiang W; Hörsten SV
    Behav Brain Res; 2024 Mar; 460():114781. PubMed ID: 38043677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo.
    Thom T; Schmitz M; Fischer AL; Correia A; Correia S; Llorens F; Pique AV; Möbius W; Domingues R; Zafar S; Stoops E; Silva CJ; Fischer A; Outeiro TF; Zerr I
    Mov Disord; 2022 Jan; 37(1):39-51. PubMed ID: 34448510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.
    Koss DJ; Erskine D; Porter A; Palmoski P; Menon H; Todd OGJ; Leite M; Attems J; Outeiro TF
    Acta Neuropathol Commun; 2022 Jul; 10(1):98. PubMed ID: 35794636
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Caputo A; Liang Y; Raabe TD; Lo A; Horvath M; Zhang B; Brown HJ; Stieber A; Luk KC
    eNeuro; 2020; 7(4):. PubMed ID: 32788297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct tau and alpha-synuclein molecular signatures in Alzheimer's disease with and without Lewy bodies and Parkinson's disease with dementia.
    van der Gaag BL; Deshayes NAC; Breve JJP; Bol JGJM; Jonker AJ; Hoozemans JJM; Courade JP; van de Berg WDJ
    Acta Neuropathol; 2024 Jan; 147(1):14. PubMed ID: 38198008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotaxic Targeting of Alpha-Synuclein Pathology in Mouse Brain Using Preformed Fibrils.
    Zhang B; Kehm V; Gathagan R; Leight SN; Trojanowski JQ; Lee VM; Luk KC
    Methods Mol Biol; 2019; 1948():45-57. PubMed ID: 30771169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.